13546-1-AP
antibody from Proteintech Group
Targeting: ST3GAL4
CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ
Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 13546-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#13546-1-AP, RRID:AB_10597402
- Product name
- ST3GAL4 antibody
- Antibody type
- Polyclonal
- Description
- ST3GAL4 antibody (Cat. #13546-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references RANK(+)TLR2(+) myeloid subpopulation converts autoimmune to joint destruction in rheumatoid arthritis.
Sialylation-dependent interaction between PD-L1 and CD169 promotes monocyte adhesion to endothelial cells.
Five hypoxia and immunity related genes as potential biomarkers for the prognosis of osteosarcoma.
ST3Gal IV Mediates the Growth and Proliferation of Cervical Cancer Cells In Vitro and In Vivo Via the Notch/p21/CDKs Pathway.
The sialyltransferase ST3Gal3 facilitates the receptivity of the uterine endometrium in vitro and in vivo.
Zhang W, Noller K, Crane J, Wan M, Wu X, Cahan P, Cao X
eLife 2023 May 19;12
eLife 2023 May 19;12
Sialylation-dependent interaction between PD-L1 and CD169 promotes monocyte adhesion to endothelial cells.
Cai K, Chen Q, Shi D, Huang S, Wang C, Ai Z, Jiang J
Glycobiology 2023 Apr 19;33(3):215-224
Glycobiology 2023 Apr 19;33(3):215-224
Five hypoxia and immunity related genes as potential biomarkers for the prognosis of osteosarcoma.
Liu D, Hu Z, Jiang J, Zhang J, Hu C, Huang J, Wei Q
Scientific reports 2022 Jan 31;12(1):1617
Scientific reports 2022 Jan 31;12(1):1617
ST3Gal IV Mediates the Growth and Proliferation of Cervical Cancer Cells In Vitro and In Vivo Via the Notch/p21/CDKs Pathway.
Wu Y, Chen X, Dong W, Xu Z, Jian Y, Xu C, Zhang L, Wei A, Yu X, Wang S, Wang Y, Liu G, Sun X, Wang S
Frontiers in oncology 2020;10:540332
Frontiers in oncology 2020;10:540332
The sialyltransferase ST3Gal3 facilitates the receptivity of the uterine endometrium in vitro and in vivo.
Yu M, Wang H, Liu J, Qin H, Liu S, Yan Q
FEBS letters 2018 Nov;592(22):3696-3707
FEBS letters 2018 Nov;592(22):3696-3707
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HeLa cells were subjected to SDS PAGE followed by western blot with 13546-1-AP(ST3GAL4 antibody) at dilution of 1:300
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human testis using 13546-1-AP(ST3GAL4 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The ST3GAL4 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human ST3GAL4. This antibody recognizes human, mouse, rat antigen. The ST3GAL4 antibody has been validated for the following applications: ELISA, WB, IHC analysis.